- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.20: 3 residues within 4Å:- Chain A: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: N.120, T.122, V.125, F.152
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.160
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: G.229, N.231
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.279
- Chain C: K.555
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: D.336, N.340
- Ligands: NAG.26
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Ligands: NAG.25
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: N.613, T.615, Q.641
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: Y.652, N.654
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: N.706, I.1127, G.1128
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.120, T.122
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.160
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: G.229, N.231
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.279
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: D.336, N.340
- Ligands: NAG.37
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Ligands: NAG.36
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: N.613, T.615, Q.641
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: Y.652, N.654
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain B: A.703, E.1069, N.1071
- Ligands: NAG.42
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Ligands: NAG.41
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: N.120, T.122, V.125
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.160
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: G.229, N.231
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.279
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: D.336, N.340
- Ligands: NAG.49
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Ligands: NAG.48
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain C: N.613, Q.641
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: Y.652, N.654
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Y. et al., Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants. Iscience (2022)
- Release Date
- 2022-06-15
- Peptides
- Spike glycoprotein: ABC
heavy chain of STS165: DFH
light chain of STS165: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
EF
HH
KE
FG
II
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Y. et al., Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants. Iscience (2022)
- Release Date
- 2022-06-15
- Peptides
- Spike glycoprotein: ABC
heavy chain of STS165: DFH
light chain of STS165: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
EF
HH
KE
FG
II
L